89 related articles for article (PubMed ID: 8754418)
21. Hepatitis C and immune globulin.
Douglas SD; Slade HB
N Engl J Med; 1995 May; 332(18):1235; author reply 1236-7. PubMed ID: 7700323
[No Abstract] [Full Text] [Related]
22. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing.
Murokawa H; Yoshikawa A; Ohnuma H; Iwata A; Katoh N; Miyamoto M; Mine H; Emura H; Tadokoro K;
Vox Sang; 2005 Jan; 88(1):10-6. PubMed ID: 15663717
[TBL] [Abstract][Full Text] [Related]
23. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS).
Murphy EL; Bryzman SM; Glynn SA; Ameti DI; Thomson RA; Williams AE; Nass CC; Ownby HE; Schreiber GB; Kong F; Neal KR; Nemo GJ
Hepatology; 2000 Mar; 31(3):756-62. PubMed ID: 10706569
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus.
Ramos-Casals M; Font J; García-Carrasco M; Cervera R; Jiménez S; Trejo O; de la Red G; Sánchez-Tapias JM; Ingelmo M
Arthritis Rheum; 2000 Dec; 43(12):2801-6. PubMed ID: 11145039
[TBL] [Abstract][Full Text] [Related]
26. Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation.
File E; Mehra M; Nair S; Dumas-Hicks D; Perrillo R
Transplantation; 2003 Oct; 76(7):1096-100. PubMed ID: 14557759
[TBL] [Abstract][Full Text] [Related]
27. Clinical and epidemiological assessment of hepatitis C virus infection among voluntary blood donors.
ŁAbedzka H; Simon K; Gładysz A
Med Sci Monit; 2002 Aug; 8(8):CR591-6. PubMed ID: 12165747
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and clinical features of hepatitis G virus infection in bone marrow allograft recipients.
Corbi C; Traineau R; Esperou H; Ravera N; Portelette E; Benbunan M; Gluckman E; Loiseau P
Bone Marrow Transplant; 1997 Dec; 20(11):965-8. PubMed ID: 9422476
[TBL] [Abstract][Full Text] [Related]
29. Use of nucleic acid testing for blood donor screening of human immunodeficiency virus and hepatitis C virus in the Saudi population.
Akhter J; Roberts GT; Perry A; Gaucher JS; Howman PA
Saudi Med J; 2001 Dec; 22(12):1073-5. PubMed ID: 11802179
[TBL] [Abstract][Full Text] [Related]
30. The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.
Deterding K; Wiegand J; Grüner N; Hahn A; Jäckel E; Jung MC; Buggisch P; Galle P; Berg T; Hinrichsen H; Potthoff A; Zeuzem S; Cornberg M; Manns M; Wedemeyer H
Z Gastroenterol; 2009 Jun; 47(6):531-40. PubMed ID: 19533544
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of hepatitis C virus infection in the Poitou- Charentes region].
Frère T; Verneau A; Besson I; de Bayser L; Dupuychaffray JP; Kitmacher P; Silvain C; Beauchant M
Gastroenterol Clin Biol; 1999; 23(8-9):887-91. PubMed ID: 10533141
[TBL] [Abstract][Full Text] [Related]
32. Transmission of viral infections through intravenous immune globulin.
Schiff RI
N Engl J Med; 1994 Dec; 331(24):1649-50. PubMed ID: 7969346
[No Abstract] [Full Text] [Related]
33. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
Ahmad N; Asgher M; Shafique M; Qureshi JA
Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
[TBL] [Abstract][Full Text] [Related]
34. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
Kretzschmar E; Chudy M; Nübling CM; Ross RS; Kruse F; Trobisch H
Vox Sang; 2007 May; 92(4):297-301. PubMed ID: 17456153
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors of hepatitis C infection after cardiac surgery in childhood before and after blood donor screening.
Vogt M; Mühlbauer F; Braun SL; Lang T; Busch R; Lange R; Frösner G; Hess J
Infection; 2004 Jun; 32(3):134-7. PubMed ID: 15188071
[TBL] [Abstract][Full Text] [Related]
36. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
37. National guideline for the management of the viral hepatitides A, B, and C. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Sex Transm Infect; 1999 Aug; 75 Suppl 1():S57-64. PubMed ID: 10616387
[No Abstract] [Full Text] [Related]
38. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
Luksamijarulkul P; Thammata N; Sujirarat D; Tiloklurs M
Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
[TBL] [Abstract][Full Text] [Related]
39. Transmission of hepatitis after the administration of intravenous immunoglobulins.
Rousell RH; Dobkin MB; Budinger MD; Louie RE
Am J Clin Pathol; 1993 May; 99(5):649. PubMed ID: 8493958
[No Abstract] [Full Text] [Related]
40. Hepatitis C virus transmission.
Garozzo G; Bonomo P; Distefano R; Rizzone P
Eur J Med; 1993 May; 2(5):316. PubMed ID: 8252171
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
